Agenus | AGEN - Ebit





Ebit Veränderung Datum
AbbVie USD 4.73B 1.08B 2026-03
Agenus USD 14.4M 19.26M 2025-12
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Celldex Therapeutics USD -84.44M 2.72M 2026-03
CSL USD 2.64B 116M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Incyte USD 344.17M 39.71M 2026-03
Intrexon USD -26.3M 2.91M 2024-06
J&J USD 6.62B 1.51B 2026-03
Jiangsu Hengrui CNY 2.56B 302M 2026-03
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
Merck EUR 1.05B 572M 2026-03
Merck USD -1.88B 8.12B 2026-03
Northwest Biotherapeutics USD -14.32M 822K 2025-09
Novartis USD 4.18B 118M 2026-03
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.99B 340M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Veracyte USD 19.08M 5.55M 2026-03